moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TALS Talaris Therapeutics > Company Executives
TALS Talaris Therapeutics
Post Mkt Price
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Scott RequadtPresident, Chief Executive Officer, Secretary and Director748.06K----54male04/29/2022
Ms. Mary Kay FentonChief Financial Officer, Treasurer and Principal Accounting Officer------58female04/29/2022
Dr. Suzanne T. Ildstad, M.D.Chief Scientific Officer and Director561.73K----69female04/29/2022
Dr. Nancy Krieger, M.D.Chief Medical Officer591.31K----56female04/29/2022
Mr. Michael ZdanowskiChief Technology Officer------55male04/29/2022
Dr. Francois Nader,M.D.Chairman of the Board83.46K----65male04/29/2022
Mr. Geoff MackayDirector40.86K----55male04/29/2022
Mr. Mark D. McdadeIndependent Director27.67K----66male04/29/2022
Dr. Sapna Srivastava, PhDIndependent Director412.18K----51female04/29/2022
Dr. Karen L. Smith, M.D.,PhDIndependent Director--------female05/17/2022
Dr. Gaurav Shah, M.D.Independent Director37.60K----47male04/29/2022
Mr. Sandip AgarwalaIndependent Director27.67K----42male04/29/2022
Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Hot List
SymbolLatest price%Chg